Testing effectiveness (Phase 2)Ended earlyNCT01056601
What this trial is testing
Panobinostat & Bortezomib in Pancreatic Cancer Progressing on Gemcitabine Therapy
Who this might be right for
Pancreatic Cancer
Masonic Cancer Center, University of Minnesota 7